home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Towards Better Anti-Epileptic Drugs

  October, 27 2006 14:34
your information resource in human molecular genetics
A completely new way of suppressing epileptic seizures in rats is reported in a study to be published in the November issue of Nature Neuroscience. The results of the study suggest that glycolysis inhibitors offer a potential new treatment strategy for epilepsy.

Epilepsy affects 1% of people worldwide. Currently available drugs, however, fail to control seizures in a third of patients. Avtar Roopra, Tom Sutula and colleagues were inspired by the fact that, in some patients, severe epilepsy is improved by a diet that completely avoids all carbohydrates. The 'ketogenic' diet has been known for decades, but no one understood why or how it worked. Glycolysis, the process by which carbohydrates are broken down, is inhibited in patients as a result of the diet. The authors treated epileptic rats with an inhibitor of glycolysis, and report that this dramatically reduced the number and severity of seizures in the animals.

Roopra and colleagues suspected that one of the glycolysis end products might increase nerve cell excitability; inhibiting glycolysis would therefore reduce nerve cell excitability and the likelihood of seizures. They found that one product of glycolysis, NADH, increases the expression of certain pro-excitability genes in nerve cells, and inhibiting glycolysis reduced the expression of these genes.

Author contact:

Avtar Roopra (University of Wisconsin-Madison, Madison, WI, USA)
E-mail: roopra@neurology.wisc.edu

Tom Sutula (University of Wisconsin-Madison, Madison, WI, USA)
E-mail: sutula@neurology.wisc.edu

Abstract available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.